Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Program Planners, Administrators, & Project Managers
- Remove Parents & Caregivers
- Remove Prevention Professionals
- Remove Alcoholism
- Remove Opioid Use Disorder
- Remove Medication-Assisted Treatment
- Remove Substance Abuse Screening
- Remove Brief Intervention
- Remove Education
- Remove Emergency Department Treatment
Main page content
TIP 63: Medications for Opioid Use Disorder - Full Document
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder
Published: January 2021
This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
Talk. They Hear You: Partner Toolkit
Published: February 2016
Provides parents of children ages 9 to 15 with the tools and information they need to start talking with their children early about the dangers of alcohol. Includes a suite of materials that helps reinforce the underage drinking prevention campaign's messages. Find the Partner Toolkit here.